InsiderTrades.com logo
Ever heard of this 8-day bitcoin profit window?
From DTI   |   Ad
Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.
It’s coming up quick.
Jennifer Kayden Lee net worth and biography
  • Phone
  • Email
  • Website

Jennifer Lee Biography and Net Worth

EVP of Rhythm Pharmaceuticals
Jennifer Lee joined Rhythm Pharmaceuticals in November 2020 as Executive Vice President North America. Jennifer brings more than 20 years of strategy and commercial experience in rare diseases. Most recently, she was the Chief Commercial Officer at Krystal Biotech. Prior to that, she served as Vice President, Head of Genetic Diseases at Sanofi Genzyme, where she was responsible for the U.S. commercial strategy and implementation for seven brands and launch preparation within rare diseases. During her time at Sanofi Genzyme, Jennifer also held leadership roles as Vice President, Head of Global Nephrological Diseases, Senior Director of Global Marketing in Fabry disease, Senior Director of Global Market Access and International Marketing for the cardiovascular business, and Director of Business Development. Jennifer holds a Bachelor of Science degree from Massachusetts Institute of Technology and a master’s in public health from Harvard University.

What is Jennifer Kayden Lee's net worth?

The estimated net worth of Jennifer Kayden Lee is at least $58,261.68 as of November 11th, 2024. Ms. Lee owns 972 shares of Rhythm Pharmaceuticals stock worth more than $58,262 as of November 23rd. This net worth approximation does not reflect any other investments that Ms. Lee may own. Additionally, Ms. Lee receives a salary of $727,140.00 as EVP at Rhythm Pharmaceuticals. Learn More about Jennifer Kayden Lee's net worth.

How old is Jennifer Kayden Lee?

Ms. Lee is currently 48 years old. There are 5 older executives and no younger executives at Rhythm Pharmaceuticals. The oldest executive at Rhythm Pharmaceuticals is Dr. David P. Meeker M.D., Chairman, President & CEO, who is 70 years old. Learn More on Jennifer Kayden Lee's age.

What is Jennifer Kayden Lee's salary?

As the EVP of Rhythm Pharmaceuticals, Inc., Ms. Lee earns $727,140.00 per year. There are 3 executives that earn more than Ms. Lee. The highest earning executive at Rhythm Pharmaceuticals is Dr. David P. Meeker M.D., Chairman, President & CEO, who commands a salary of $1,350,000.00 per year. Learn More on Jennifer Kayden Lee's salary.

How do I contact Jennifer Kayden Lee?

The corporate mailing address for Ms. Lee and other Rhythm Pharmaceuticals executives is 222 BERKELEY STREET 12TH FLOOR, BOSTON MA, 02116. Rhythm Pharmaceuticals can also be reached via phone at (857) 264-4280 and via email at [email protected]. Learn More on Jennifer Kayden Lee's contact information.

Has Jennifer Kayden Lee been buying or selling shares of Rhythm Pharmaceuticals?

Over the course of the past ninety days, Jennifer Kayden Lee has sold $4,434,890.13 in Rhythm Pharmaceuticals stock. Most recently, Jennifer Kayden Lee sold 66,861 shares of the business's stock in a transaction on Monday, November 11th. The shares were sold at an average price of $66.33, for a transaction totalling $4,434,890.13. Following the completion of the sale, the executive vice president now directly owns 972 shares of the company's stock, valued at $64,472.76. Learn More on Jennifer Kayden Lee's trading history.

Who are Rhythm Pharmaceuticals' active insiders?

Rhythm Pharmaceuticals' insider roster includes Pamela Cramer (Insider), Jennifer Good (Director), Jennifer Lee (EVP), Yann Mazabraud (EVP), David Meeker (CEO), Joseph Shulman (Insider), Hunter Smith (CFO), and Lynn Tetrault (Director). Learn More on Rhythm Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Rhythm Pharmaceuticals?

In the last twelve months, insiders at the sold shares 26 times. They sold a total of 410,931 shares worth more than $20,497,452.48. The most recent insider tranaction occured on November, 11th when EVP Jennifer Kayden Lee sold 66,861 shares worth more than $4,434,890.13. Insiders at Rhythm Pharmaceuticals own 5.6% of the company. Learn More about insider trades at Rhythm Pharmaceuticals.

Information on this page was last updated on 11/11/2024.

Jennifer Kayden Lee Insider Trading History at Rhythm Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/11/2024Sell66,861$66.33$4,434,890.13972View SEC Filing Icon  
11/8/2023Sell5,712$28.90$165,076.801,647View SEC Filing Icon  
11/3/2023Sell80$28.00$2,240.001,647View SEC Filing Icon  
9/5/2023Sell6,166$28.05$172,956.301,647View SEC Filing Icon  
8/9/2023Sell1,718$24.66$42,365.883,294View SEC Filing Icon  
8/7/2023Sell11,223$24.18$271,372.143,294View SEC Filing Icon  
See Full Table

Jennifer Kayden Lee Buying and Selling Activity at Rhythm Pharmaceuticals

This chart shows Jennifer Kayden Lee's buying and selling at Rhythm Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rhythm Pharmaceuticals Company Overview

Rhythm Pharmaceuticals logo
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $59.94
Low: $59.00
High: $60.25

50 Day Range

MA: $53.35
Low: $47.20
High: $67.33

2 Week Range

Now: $59.94
Low: $31.52
High: $68.58

Volume

302,442 shs

Average Volume

708,100 shs

Market Capitalization

$3.68 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.09
Ever heard of this 8-day bitcoin profit window?
From DTI   |   Ad
Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.
It’s coming up quick.